News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
D'Onofrio Matthew J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 300,000 options to buy
@ $2.68, valued at
$804k
|
|
| 12/14/2020 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Sold 5,643 shares
@ $2.95, valued at
$16.6k
Sold 40,357 shares
@ $2.91, valued at
$117.4k
|
|
| 12/11/2020 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Exercised 46,000 options to buy
@ $0.4, valued at
$18.4k
|
|
| 09/02/2020 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Acquired 20,238 shares
@ $1.05, valued at
$21.2k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Disposed/sold 65,000 options to buy
@ $3.07, valued at
$199.6k
Disposed/sold 70,687 options to buy
@ $3.04, valued at
$214.9k
Disposed/sold 52,500 options to buy
@ $3.04, valued at
$159.6k
Disposed/sold 150,000 options to buy
@ $2.36, valued at
$354k
Disposed/sold 150,000 options to buy
@ $2.43, valued at
$364.5k
Disposed/sold 150,000 options to buy
@ $2.94, valued at
$441k
Granted 48,750 options to buy
@ $0.62, valued at
$30.2k
Granted 53,015 options to buy
@ $0.62, valued at
$32.9k
Granted 39,375 options to buy
@ $0.62, valued at
$24.4k
Granted 112,500 options to buy
@ $0.62, valued at
$69.8k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2018 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Acquired 13,036 shares
@ $1.63, valued at
$21.2k
|
|
| 04/27/2018 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 150,000 options to buy
@ $2.43, valued at
$364.5k
|
|
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/03/2013 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 94,250 options to buy
@ $8.67, valued at
$817.1k
|
|
|
|